Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Meiners

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Oncotarget|August 28, 2019
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomyCornelia Schroeder, Elham Navid-Hill, Jan Meiners, et al.
Cancers|March 10, 2022
PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic PowerAlexandra M Poos, Cornelia Schroeder, Neeraja Jaishankar, et al.
Oncotarget|January 7, 2020
Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusionStefan Steurer, Lara Schwemmer, Claudia Hube-Magg, et al.
Cancer Biology & Medicine|September 14, 2019
Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of <i>PTEN</i> deleted prostate cancersAndreas M Luebke, Ali Attarchi-Tehrani, Jan Meiners, et al.
Disease Markers|May 8, 2020
Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate CancerAndreas Marx, Andreas M Luebke, Till S Clauditz, et al.
Biomedicines|December 24, 2021
Angiotensin-Converting Enzyme 2 Protein Is Overexpressed in a Wide Range of Human Tumour Types: A Systematic Tissue Microarray Study on >15,000 TumoursJan Meiners, Kristina Jansen, Natalia Gorbokon, et al.
Pathology Oncology Research : POR|July 18, 2020
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG FusionsChristian Bernreuther, Ferdous Daghigh, Katharina Möller, et al.
Oncology Letters|October 16, 2019
Upregulation of SPDEF is associated with poor prognosis in prostate cancerJan Meiners, Katharina Schulz, Katharina Möller, et al.
Aging|September 19, 2019
Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancerPatrick Lebok, Aurelia von Hassel, Jan Meiners, et al.
Gastroenterology|June 26, 2020
IL22BP Mediates the Antitumor Effects of Lymphotoxin Against Colorectal Tumors in Mice and HumansJan Kempski, Anastasios D Giannou, Kristoffer Riecken, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Oncotarget|August 28, 2019
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomyCornelia Schroeder, Elham Navid-Hill, Jan Meiners, et al.
Cancers|March 10, 2022
PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic PowerAlexandra M Poos, Cornelia Schroeder, Neeraja Jaishankar, et al.
Oncotarget|January 7, 2020
Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusionStefan Steurer, Lara Schwemmer, Claudia Hube-Magg, et al.
Cancer Biology & Medicine|September 14, 2019
Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of <i>PTEN</i> deleted prostate cancersAndreas M Luebke, Ali Attarchi-Tehrani, Jan Meiners, et al.
Disease Markers|May 8, 2020
Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate CancerAndreas Marx, Andreas M Luebke, Till S Clauditz, et al.
Biomedicines|December 24, 2021
Angiotensin-Converting Enzyme 2 Protein Is Overexpressed in a Wide Range of Human Tumour Types: A Systematic Tissue Microarray Study on >15,000 TumoursJan Meiners, Kristina Jansen, Natalia Gorbokon, et al.
Pathology Oncology Research : POR|July 18, 2020
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG FusionsChristian Bernreuther, Ferdous Daghigh, Katharina Möller, et al.
Oncology Letters|October 16, 2019
Upregulation of SPDEF is associated with poor prognosis in prostate cancerJan Meiners, Katharina Schulz, Katharina Möller, et al.
Aging|September 19, 2019
Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancerPatrick Lebok, Aurelia von Hassel, Jan Meiners, et al.
Gastroenterology|June 26, 2020
IL22BP Mediates the Antitumor Effects of Lymphotoxin Against Colorectal Tumors in Mice and HumansJan Kempski, Anastasios D Giannou, Kristoffer Riecken, et al.
Pageof 3